SEC Filing Summary: Ceracor Inc. (CERC)
Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held on June 15, 2021. The registrant is Ceracor Inc., a Delaware corporation trading on the Nasdaq Capital Market under the symbol CERC. Note: The request metadata referenced "Avalo Therapeutics, Inc.," but the filing text explicitly identifies the registrant as Ceracor Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
As of the record date (April 22, 2021), there were 95,457,198 shares outstanding. Approximately 82.05% of shares (78,321,287) were present or represented by proxy.
- Proposal 1: Election of Directors All eight nominees were elected. However, a substantial majority of withheld votes for each nominee were attributed to the Company's largest stockholder, an investment fund directed by a board member.
- Proposal 2: Ratification of Auditors Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2021.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, or specific risk factors beyond the noted dissent from the largest stockholder regarding director elections.
Investor Verification Checklist
- Verify the identity of the registrant (Ceracor Inc.) versus the metadata reference (Avalo Therapeutics).
- Review the identity and rationale of the largest stockholder who withheld votes for all director nominees.
- Confirm the appointment of Ernst & Young LLP as the auditor for the 2021 fiscal year.
- Check subsequent filings for financial data, as this 8-K contains no financial metrics.